Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/978-3-030-59261-5_11 http://scihub22266oqcxt.onion/10.1007/978-3-030-59261-5_11 33656719!ä!33656719       Adv+Exp+Med+Biol 2021 ; 1321 (ä): 127-138 Nephropedia Template TP {{tp|p=33656719|t=2021. The Novel Coronavirus and Inflammation |pdf=|usr=}}{{33656719}} gab.com Text The Novel Coronavirus and Inflammation JO: Adv Exp Med Biol http://www.kidney.de/pget.php?&tw=1&pmid=33656719 #FOAvip The SARS-CoV-2 virus which causes COVID-19 disease was initially described in the Hubei Province of China and has since spread to more than 200 countries and territories of the world. Severe cases of the disease are characterised by release of high levels of pro-inflammatory cytokines and other inflammatory mediators in a process characterised as a cytokine storm. These inflammatory mediators are associated with pathological leukocyte activation states with tissue damage. Here, we review these effects with a focus on their potential use in diagnosis, patient stratification and prognosis, as well as new drug targets. Twit Text FOAVip The Novel Coronavirus and Inflammation ????Adv Exp Med Biol http://www.kidney.de/pget.php?&tw=1&pmid=33656719 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33656719 #FOAvip English Wikipedia <ref>{{Cite pmid|33656719}}</ref> The Novel Coronavirus and Inflammation #MMPMID33656719 George JA; Mayne ES Adv Exp Med Biol 2021[]; 1321 (ä): 127-138 PMID33656719show ga The SARS-CoV-2 virus which causes COVID-19 disease was initially described in the Hubei Province of China and has since spread to more than 200 countries and territories of the world. Severe cases of the disease are characterised by release of high levels of pro-inflammatory cytokines and other inflammatory mediators in a process characterised as a cytokine storm. These inflammatory mediators are associated with pathological leukocyte activation states with tissue damage. Here, we review these effects with a focus on their potential use in diagnosis, patient stratification and prognosis, as well as new drug targets. |*COVID-19[MESH] |*SARS-CoV-2[MESH] |China[MESH] |Cytokine Release Syndrome[MESH] |Cytokines[MESH] |Humans[MESH]The Novel Coronavirus and Inflammation (epmc).pdf DeepDyve Pubget Overpricing